Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI

Neuroradiology

Volumn 57, Issue 7, 2015, Pages 671-678

  Artzi, Moran ^a,b   Liberman, Gilad ^a   Nadav, Guy ^a,b   Vitinshtein, Faina ^a   Blumenthal, Deborah T ^a   Bokstein, Felix ^a   Aizenstein, Orna ^a   Bashat, Dafna Ben ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brain tumor; Cerebral blood volume; Dynamic contrast enhancement; Dynamic susceptibility contrast; MRI

Indexed keywords

ADULT; ARTICLE; BLOOD VOLUME; BRAIN ARTERY; BRAIN BLOOD VOLUME; BRAIN TUMOR; CANCER PATIENT; CHOROID PLEXUS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIAL SINUS; FEMALE; GLIOBLASTOMA; GLOMERULUS FILTRATION RATE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PLASMA VOLUME; PRIORITY JOURNAL; WHITE MATTER; BRAIN CIRCULATION; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

CONTRAST MEDIUM;

ADULT; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84937521636     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-015-1518-4     Document Type: Article

References (31)

1. Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER (2006) Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 26(Suppl 1):S173–S189
2. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487
3. Law M (2009) Advanced imaging techniques in brain tumors. Cancer Imaging 9 Spec No A: S4-9
4. Law M, Yang S, Wang H, Babb JS, Johnson G et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998
5. Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E (2012) Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum—use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198:19–26
6. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C et al (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 36:726–736
7. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36:715–725
8. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K (2009) Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 62:205–217
9. Sourbron SP, Heilmann M, Biffar A, Walczak C, Vautier J et al (2008) Tracer kinetic analysis of a simultaneous T1- and T2* measurement in a tumor model. The International Society for Magnetic Resonance in Medicine, Toronto Ontario Canada
10. Vonken EP, van Osch MJ, Bakker CJ, Viergever MA (2000) Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 43:820–827
11. Sourbron SP, Buckley DL (2013) Classic models for dynamic contrast-enhanced MRI. NMR Biomed 26:1004–1027
12. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232
13. Jain R (2013) Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. NMR Biomed 26:1042–1049
14. Pope WB, Young JR, Ellingson BM (2011) Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep 11:336–344
15. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR et al (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92:1599–1610
16. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17:357–367
17. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM et al (1998) Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 171:941–949
18. Larsen VA, Simonsen HJ, Law I, Larsson HB, Hansen AE (2013) Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55:361–369
19. Liberman G, Louzoun Y, Ben Bashat D (2013) T1 mapping using variable flip angle SPGR data with flip angle correction. Imaging, Journal of Magnetic Resonance
20. Liberman G, Nadav G, Louzoun Y, Artzi M, Ben Bashat D (2014) Bolus arrival time extraction using super temporal resolution analysis of DCE. The International Society for Magnetic Resonance in Medicine, Milan, Italy
21. Deoni SC, Peters TM, Rutt BK (2005) High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn Reson Med 53:237–241
22. Deoni SC (2007) High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI). J Magn Reson Imaging 26:1106–1111
23. Deoni SC, Rutt BK, Peters TM (2003) Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 49:515–526
24. Fluckiger JU, Schabel MC, Dibella EV (2009) Model-based blind estimation of kinetic parameters in dynamic contrast enhanced (DCE)-MRI. Magn Reson Med 62:1477–1486
25. Murase K (2004) Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 51:858–862
26. Bagher-Ebadian H, Jain R, Nejad-Davarani SP, Mikkelsen T, Lu M et al (2012) Model selection for DCE-T1 studies in glioblastoma. Magn Reson Med 68:241–251
27. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–867
28. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–S219
29. Artzi M, Aizenstein O, Jonas-Kimchi T, Myers V, Hallevi H et al (2013) FLAIR lesion segmentation: application in patients with brain tumors and acute ischemic stroke. Eur J Radiol 82:1512–1518
30. Awasthi R, Pandey CM, Sahoo P, Behari S, Kumar V et al (2012) Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. J Comput Assist Tomogr 36:125–130
31. Nadav G, Liberman G, Artzi M, Kiryati N, Ben Bashat D (2014) Flow and permeability estimation from DCE data: 2-compartment exchange and Tofts models comparison. The International Society for Magnetic Resonance in Medicine, Milan, Italy